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Case-control studies in major depression have established patterns of regional gray matter 
loss, including the hippocampus, which might show state-related effects dependent on 
disease stage. However, there is still limited knowledge on compensation effects that 
might occur in people resilient to depression showing only subclinical symptoms. We used 
voxel-based morphometry on a multicenter data set of 409 healthy nonclinical subjects 
to test the hypothesis that local hippocampal volume would be inversely correlated with 
subclinical depressive symptoms [Symptom Checklist 90-Revised (SCL-90-R) depression 
scores]. Our region-of-interest results show a significant ( p = 0.042, FWE cluster-level 
corrected) positive correlation of SCL-90-R scores for depression and a left hippocampus 
cluster. Additionally, we provide an exploratory finding of gyrification, a surface-based 
morphometric marker, correlating with a right postcentral gyrus cluster [ p = 0.031, family-
wise error (FWE) cluster-level corrected]. Our findings provide first preliminary evidence 
of an inverse relationship for subjects in the absence of clinical depression and might 
thus point to processes related to compensation. Similar effects have been observed in 
remission from major depression and thus deserve further study to evaluate hippocampal 
volume not only as a state-dependent marker of disease but also of resilience.
Keywords: depression, imaging, neuroanatomy, healthy subjects, gyrification, surface-based morphometry, 
subclinical, voxel-based morphometry
INTRODUCTION
Major depression is associated with brain structural changes documented in several imaging 
studies. A recent mega-analysis has demonstrated brain matter reductions in multiple cortical areas, 
including the orbital frontal cortex, cingulate and insular cortex, and temporal lobes (1). Many 
of these changes are already evident at first episode (2). Of these changes, the hippocampus is of 
particular interest because it has been proposed as both a state marker and a putative biomarker for 
treatment outcome in major depression (3). Hippocampal volume has repeatedly been suggested as a 
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predictor of treatment, including pharmacological antidepressive 
treatment (4) and electroconvulsive therapy (5, 6). Hippocampal 
volume has also been shown to potentially distinguish between 
remitting and nonremitting patients at 1-year follow-up (7). 
Although there might be some genetic effects of liability to 
depression related to hippocampal volume (8), there are clearly 
state-dependent effects related to depressive phenotype in 
hippocampal gray matter volume (9).
Resilience to psychopathology and compensation are 
underestimated factors in these anatomical models of depressive 
symptoms and depressive disorder. These might not be captured 
in typical approaches to imaging studies of depression, which 
rely on case–control designs. Although these studies have largely 
increased our understanding of the anatomy of major depression, 
they still lack good mechanistic models for compensation that 
leads to either remission of existing symptoms or individual 
resilience preventing individuals from developing manifest 
depressive psychopathology. Also, they do not account very well 
for dimensional approaches to depression. Not only do depressive 
symptoms occur in a number of psychiatric conditions other 
than major depression, they might also arise (at least transiently) 
in a large proportion of nonclinical subjects, for example, after 
stressful life events or at times of higher stress. Many individuals 
suffering such stress, often related to environmental 
impact, however do not develop manifest depression. Also, 
depressive symptoms are very common in a number of other 
psychiatric disorders, such as anxiety disorders, somatization, 
eating disorders, psychosis, and so on. Therefore, our understanding 
of hippocampal structure and a dimensional depressive phenotype 
will have to depend on studying subjects across a wider spectrum 
of both clinical pathologies and the subclinical spectrum (i.e., 
subjects without a psychiatric disorder).
Indeed, in recent studies, healthy subjects with a family 
history of major depression who show resilience to developing a 
clinical phenotype have been shown to have relatively greater or 
intact hippocampal volume (10). If relatively larger or preserved 
hippocampal volume is predictive of a higher probability for 
remission in major depression and higher hippocampal volume 
in nonclinical subjects might be a potential indicator of resilience, 
one would expect to find not only negative correlations between 
regional brain volumes and depressive symptoms, but also positive 
correlations indicative of resilience and overcompensation. In a 
recent study of 177 healthy participants (11), we identified 
positive gray matter correlations with depressive, anxiety, and 
somatization symptoms across the number of cortical regions. 
Several smaller studies in healthy subjects have identified either 
similar or nonoverlapping cortical areas showing both negative 
and positive correlations to minor depressive symptoms.
In the present study, we sought to use a large data set from a 
multicenter study (12, 13) to test specifically the hypothesis 
that hippocampal volume (as well as other regional brain 
volumes) might also show anticorrelation with minor nonclinical 
symptoms of depression. Testing this hypothesis in a nonclinical 
data set would allow us to avoid potential contamination 
induced by either changes related to the manifest emergence of 
a psychiatric disorder or effects related to medication or other 
forms of treatment. We therefore tested this hypothesis first for 
the hippocampus and then in addition on a whole-brain level to 
identify in particular those areas showing positive correlations to 
nonclinical depressive symptomatology as a potential indicator 
of resilience.
METHODS
Participants
For this study, we relied on a multicenter sample of 409 clinically 
healthy young adults from Jena, Germany, and Verona, Italy, for 
which we have already published analyses on aggressive traits 
(12) and subclinical agoraphobic symptoms (13). The sample 
also includes a subsample of 177 healthy subjects, for whom we 
have published voxel-based morphometry (VBM) analyses of 
subclinical depressive, general anxiety, and somatization symptoms 
(11). As outlined in our previous work on this multicenter sample, 
this included three subsamples: 177 healthy subjects from Jena 
(Jena-1 sample), 141 healthy subjects from Jena (Jena-2 sample) 
for whom data were acquired after a major hardware and software 
upgrade of the magnetic resonance imaging (MRI) scanner and 
who are thus treated as a separate sample, and finally 91 healthy 
subjects from Verona, Italy (Verona/Milano sample).
All study participants provided written informed consent 
to protocols approved by the local Ethics Committee of Jena 
University Medical School and the Ethics Committee of the 
Azienda Ospedaliera Universitaria of Verona.
Demographic details and recruitment for this multicenter 
cohort have been described previously (12, 13). In brief, we 
included healthy subjects meeting the following criteria: age 
18 or above and ability to provide written informed consent. 
The exclusion criteria defined for both samples were current 
or previous psychiatric disorders (axis I), central nervous 
neurological disorders, traumatic brain injury with loss of 
consciousness, learning disability, or contraindication for MRI 
scans, major neurological and unmedicated internal medical 
conditions, and psychiatric history in first-degree relatives. For 
exclusion of persons with a present or history of Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 
axis I disorders, we used careful screening via phone in the Jena 
samples and a modified Structured Clinical Interview for DSM-IV 
Axis I Disorders (SCID-IV) nonpatient version (SCID-NP) 
interview derived in the Verona/Milano sample. IQ was estimated 
using the MWT-B (Mehrfach-Wortschatz-Intelligenztest), a 
German-language inventory (14) similar to the NART (National 
Adult Reading Text) in the two Jena samples, and the Italian 
version of the Wechsler Adult Intelligence Scale-Revised (15, 16) 
for the Verona/Milano sample. This also allowed us to confirm 
that none of the participants had an estimated IQ of 80 or lower.
For characterization of subclinical depression symptoms, 
we used the Symptom Checklist 90-Revised (SCL-90-R) scale, 
as in previous studies including other symptom dimensions. 
As outlined previously (Besteher et al., Front Psychiatry, in 
press), the SCL-90-R is a self-rating instrument for a broad 
range of psychopathological symptoms (17). It is very widely 
used, with more than 1,000 studies making use of it either in 
clinical measurements of distress/symptoms/psychopathology 
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or for characterization of nonclinical samples (18). Subjects 
were asked to complete the questionnaire around the time of 
MRI scanning, indicating their responses to the 90 items on 0–4 
Likert-type scales. Previous extensive psychometric studies have 
established factor analytic solutions, which have also resulted in 
one “depression” scale, consisting of 13 questions. We used the 
mean value of these questions to generate the SCL90R score for 
depression (range 0–4).
An overview of demographic and psychometric data is given 
in Table 1.
Magnetic Resonance Imaging
MRI scans were acquired on a Siemens Tim Trio in Jena and 
Siemens Magnetom Allegra Syngo MR 2004A for the Verona/
Milano sample.
Scan parameters for the three subsamples were as follows:
Jena-1 sample: 3 Tesla Siemens Tim Trio scanner (Siemens, 
Erlangen, Germany), standard quadrature head coil and a 
T1-weighted axial 3-dimensional magnetization prepared rapid 
gradient echo (MP-RAGE) sequence (TR 2,300 ms, TE 3.03 ms, 
α 9°, 192 contiguous sagittal slices, FoV 256 mm, voxel resolution 
1 × 1 × 1 mm; acquisition time 5:21 min).
Jena-2 sample: 3 Tesla Siemens Prisma fit system (Siemens, 
Erlangen, Germany), that is, the scanner used for the Jena-1 
sample after hardware and software changes to upgrade this 
to a Prisma system; standard quadrature head coil; MP-RAGE 
sequence with parameters similar to Jena-1 sample (TR 2,300 ms, 
TE 2.07 ms, α 9°, 192 contiguous sagittal slices, field-of-view 256 
mm, voxel resolution 1 × 1 × 1 mm; acquisition time 5:21 min).
Verona/Milano sample: 3 Tesla Magnetom Allegra Syngo 
MR 2004A (Siemens, Erlangen, Germany); standard head 
coil for radio frequency transmission and reception of the MRI 
signal; T1-weighted MP-RAGE sequence (TR 2,060 ms, TE 3.93 ms, 
α 15°, 160 contiguous sagittal slices, field-of-view 256 mm, voxel 
resolution 1 × 1 × 1 mm; acquisition time 7:32 min).
Quality assurance for the MRI scans included visual inspection 
for gross artifacts (after scanning) and the automated quality 
check implemented in CAT12.
Voxel-Based Morphometry
We used the CAT 12 toolbox (Computational Anatomy Toolbox 12) 
of the Structural Brain Mapping group (Christian Gaser, Jena 
University Hospital, Jena, Germany), a toolbox implemented in 
SPM12 (Statistical Parametric Mapping, Institute of Neurology, 
London, UK) for VBM analyses. This included correction for 
bias-field inhomogeneities; segmentation into gray matter, white 
matter, and cerebrospinal fluid (19); and spatial normalization 
with the DARTEL algorithm (20). As described previously, 
segmentation was further extended by accounting for partial 
volume effects (21), applying adaptive maximum a posteriori 
estimations (22). We used the automated quality check protocol 
in CAT12 for further quality assurance. Also, we used smoothing 
with a Gaussian kernel of 8 mm [full width at half maximum 
(FWHM)] and an absolute gray matter threshold of 0.1 to 
minimize incorrect voxel classification, which might result in 
artifacts or spurious signals.
Gyrification Analysis
We also used the CAT12 toolbox (C. Gaser, Structural Brain 
Mapping Group, Jena University Hospital, Jena, Germany) to 
analyze local gyrification. This analysis is based on an absolute 
mean curvature approach (23). The cortical surface is extracted, 
the curvature across the surface is computed, and absolute values 
are used for further computations. We applied a 15-mm FWHM 
filter for smoothing.
Statistics
We used the general linear model implemented in SPM12 for 
statistical analyses. The analyses included a factor scanner 
(to correct for the different acquisition sites and scanner settings) 
and age.
For VBM analyses, we first performed a hippocampal region-
of-interest (ROI) analysis (small volume correction) using the 
AAL toolbox spatial definition of the left and right hippocampi. 
Given our anatomical hypothesis, we first focused on this area and, 
using the ROI approach, we restricted the search space (and thus 
the number of multiple voxel-wise comparisons). This analysis 
was corrected for multiple comparisons using the cluster-level 
FWE corrected at p < 0.05. In a second step, we provide a whole-
brain analysis, first at p < 0.05 FWE (cluster-level) corrected levels 
and then at p < 0.001 (uncorrected) for an exploratory view and 
further hypothesis-generating findings. For all VBM analyses, we 
included total intracranial volume as a nuisance variable.
For gyrification, we also applied a general linear model and 
again applied cluster-level FWE corrections at p < 0.05.
For all analyses, we computed both positive correlations 
(anticipating such a relation for compensation/markers of 
resilience) and negative correlations (conforming to the linear 
model of a continuum, in this case, across the symptom range 
within the nonclinical sample).
TABLE 1 | Demographic and psychometric data on study cohorts. Age, gender, IQ, and Symptom Checklist 90-Revised (SCL-90-R) depression subscale values, 
f—female, m—male. See also Refs. (12, 13).
Jena_1 (n = 177) Jena_2 (n = 141) Verona/Milano (n = 91)
Mean age (SD) 29.8 (±8.93) 32.12 (±14.27) 29.13 (±7.7)
Age_range 20–60 19–73 18–62
Gender 83 f, 94 m 87 f, 54 m 55 f, 36 m
Mean IQ (SD) 106.23 (±11.5) 115.87 (±14.81) 122.39 (±8.49)
Mean SCL-90 depression subscale value (SD) 0.36 (±0.44) 0.31 (±0. 38) 0.31 (±0.25)
SCL-90 depression subscale values (range) 0–2.62 0–2 0–1.23
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RESULTS
For the hippocampus ROI-based/small-volume correction VBM 
analysis, we found a significant positive correlation of voxels 
in a left hippocampus cluster within the ROI search volume 
(coordinates: −20; −28; 8; Z score 3.59; p = 0.010, FWE-corrected 
at peak level, p = 0.042, FWE-corrected at cluster level). A similar 
right hippocampus ROI cluster showed a positive correlation 
only at uncorrected levels. An overview of the exploratory 
analysis at p < 0.001 peak levels is shown in Figure 1 and Table 2 
for a comprehensive overview.
We did not find negative correlations of hippocampal ROI/
small-volume-based analyses, and exploratory analysis (p < 0.001, 
uncorrected) only revealed a small 5-voxel cluster in the right 
middle frontal cortex.
Gyrification analysis of correlation with subclinical depressive 
symptoms in the neocortex (at corrected levels) showed only one 
positive correlation in a right postcentral cortical cluster 
(p = 0.031, FWE-corrected at cluster level) and no negative 
correlations (Figure 2).
DISCUSSION
Subclinical depressive symptoms, defined as minor affective 
self-report features, are associated with brain gray matter 
variation in a part of the hippocampus. This main finding of 
our study expands the current understanding of dimensional 
psychopathology to biological findings and also provides 
some potential clues to brain structural markers of resilience. 
The positive correlation of subclinical symptom load with 
hippocampal volume prompts our discussion to effects of 
resilience, which might distinguish nonclinical from clinical 
subjects.
Our findings add to a growing recent literature expanding 
the identification of correlations between depressive symptoms 
and brain structure into the subclinical range. Initial studies, 
mostly in smaller samples, failed to identify a correlation with 
hippocampal volume but suggested prefrontal areas to be 
involved in subclinical depression (24, 25). Similarly, subsequent 
smaller studies have shown mixed effects hinting to associations 
with anterior cingulate cortex volume, pronounced in female 
subjects, but not in hippocampal volume (26, 27). Larger 
studies were then conducted in elderly community subjects 
subsequently, but these have again been inconsistent, especially 
regarding hippocampal volume (28, 29). The different age 
ranges of these previous studies make it difficult to compare 
these findings, especially because interaction effects with age 
are possible and likely. Two most recent studies in middle-aged 
TABLE 2 | Overview of significant clusters of positive correlations of gray matter 
values (GMV) with SCL-90-R depression subscale values (based on extended 
exploratory analysis at p < 0.001 uncorrected; for cluster size k > 10 voxels). 
Anatomical region Coordinates  
of peak voxel
k T
Right hippocampus 21; −24; 4 77 4.17
*Left hippocampus −16; −27; −9 131 4.1
Left superior/middle occipital gyrus −24; −84; 33 132 3.79
Right cerebellum (/vermis) 6; −45; −2 62 3.62
Right cuneus/right sup. occipital cortex 18; −90; 38 39 3.58
Right parahippocampal cortex 14; –16; –20 17 3.43
Left cerebellum (/vermis) −2; −62; −3 14 3.27
*indicates clusters surviving correction for multiple comparisons (p < 0.05, 
FWE-corrected).
FIGURE 1 | Voxel-based morphometry analysis of positive correlations between gray matter values (GMV) and SCL-90-R depression subscale value in 409 
healthy controls (exploratory post hoc analysis, p < 0.001, uncorrected). Note that the region-of-interest (ROI)/small-volume correction-based analysis for the 
left hippocampus cluster (maximum coordinate 20; −28; 8; Z score 3.59) survived correction for multiple comparisons ( p = 0.010, FWE corrected at peak level, 
p = 0.042, FWE corrected at cluster level). A correlation plot for the most significant voxel of this left hippocampus cluster [small volume correction (SVC) corrected 
analysis] is given in the right side of the figure. Spearman´s Rho for the correlation is 0.12 ( p = 0.015, two-tailed significance at p = 0.05), CI 0.024–0.216.
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cohorts (n = 192 and n = 80), however, did find some association 
of (negative) symptoms with hippocampal texture and volume 
(30, 31).
Although these previous studies give some indication of 
hippocampal volume being related to depressive symptoms in 
nonclinical subjects, most findings are limited to either small 
samples or particular age ranges. Our hippocampal finding 
therefore establishes the association in a large multicenter study 
across three cohorts across a wide age range.
The interpretation of these findings needs to consider 
the positive direction of correlations. In clinical studies of 
manifest depression, reduced hippocampal volume is related 
to acute episodes (9). Several interpretations of our findings 
are therefore at hand. First, the positive correlation could 
signal a resilience effect. Although showing slightly higher 
depression scores, healthy subjects with larger hippocampal 
volume might display compensation effects that prevent them 
from transitioning to higher levels of depressive symptoms. 
So far, it is unclear which cellular effects might be associated 
with such resilience to expressing a disease phenotype. 
A most recent study has implicated volume reduction of 
subregions CA2–CA4 of the hippocampus to be associated 
with first onset of clinical depression (whereas reductions in 
CA1 and the dentate gyrus were linked to recurrent disease) 
(32). Clearly, our cross-sectional design limits prediction of 
whether subsequent depression is more likely in those subjects 
with larger hippocampi (and higher resilience) or those with 
smaller hippocampi. An alternative possible interpretation 
would be that other factors, such as genetic liability, determine 
hippocampal volume to an extent that might result in such a 
positive correlation. Neither the previous studies nor our own 
considered indicators like polygenic risk scores to further 
explore this possibility.
We have noted in previous studies that subclinical or minute 
symptoms in nonclinical subjects might show positive rather 
than negative correlations, thus setting them apart from studies 
in clinical populations (12, 13). Future studies might therefore 
have to consider nonlinear effects across larger symptom ranges; 
for example, when including both clinical and nonclinical 
subjects in association analyses, the direction of correlations 
might be different across such putative disease-related spectra. 
This interpretation also provides a mechanistic account of 
the failure of previous studies aiming to identify hippocampal 
volume reduction as a precursor of incipient depression in 
elderly subjects (33), as multiple factors including genetic load 
and stress, but also resilience might interact to produce dynamic 
changes in hippocampal volume.
In addition to our VBM findings, our gyrification analysis 
(including neocortical but not hippocampal surfaces) did not 
show an association with minor depressive features other than 
a right postcentral cortical cluster. Although this is consistent 
with the notion that this marker of early neurodevelopment 
is not related to temporary fluctuations, it does not argue for 
early neocortical abnormalities related to subclinical symptom 
expression.
Our study needs to consider some methodological limitations. 
Although larger than most other studies on brain structure in 
subclinical symptoms and including multicenter data, further 
replication of our positive association seems warranted. Also, 
larger samples across the life span might be used to identify 
changes in associations in particular (adult) age ranges or linked 
to other demographic factors. The cross-sectional nature of our 
data (and thus lack of follow-up) precluded the use of prediction 
models to be tested.
Minor or subclinical depressive symptoms are increasingly 
recognized to be of relevance for our understanding of major 
depression and early intervention, even if those symptoms 
are only transient in nature and often unspecific reactions to 
stress or negative life events. There is increasing evidence from 
multiple studies suggesting that psychotherapy for subclinical 
depression not only is effective but also might reduce the 
incidence of major depression (34, 35). Hippocampal volume 
as a putative biomarker might aid in this endeavor (3), 
but compensation and resilience have not adequately been 
considered in these previous models. Our findings argue for 
an integration of anticorrelations as markers of resilience to 
be taken into account in mechanistic models relating brain 
structure to depressive symptoms across a wide range of 
phenotypic expression, including the subclinical range.
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